Skip to content
The GLP-1 Verdict
Menu
Ranked #318 · Grade C

Remedy Meds review

Telehealth provider offering compounded semaglutide and tirzepatide programs.

Visit Remedy Meds Assume we may earn a commission, at no cost to you. It never changes The Verdict Score, nor a word of this review.
Semaglutide
From $299/mo (starting dose, compounded)
Tirzepatide
From $399/mo (starting dose, compounded)
Coverage
Not disclosed
Brand-name
Compounded only

The scorecard

Remedy Meds scored on our six published factors. See the methodology.

Real-world results75/100
Price honesty28/100
Prescriber access57/100
Formulary choice82/100
Cancellation fairness60/100
Member support74/100

What we like

  • Both semaglutide and tirzepatide available
  • Compounded GLP-1 access

The caveats

  • Limited public information on program details

The verdict

Best for: Shoppers who want mainstream telehealth GLP-1 access. Telehealth provider offering compounded semaglutide and tirzepatide programs.

Ranked #318 of 499 providers we have reviewed — for comparison, read the CoreAge Rx review, our #1 pick. On the board it sits between PrescribedRX, 61/100 above and Remi Meds at 61/100 below, with the Vyora Wellness ruling the next one down.

Weighing it against something else? Every provider we would put in front of Remedy Meds is ranked on price honesty, prescriber access and cancellation terms. We have also ruled on it directly: CoreAge Rx vs Remedy Meds goes to CoreAge Rx, 94/100 to 61/100.

Compare with other providers

All 498 other providers we've reviewed, in our overall ranking order.

Every other program we track (492)

Pricing, states and verification reflect Remedy Meds's public disclosures at last review; the Verdict Score is our editorial judgment per the methodology. Prices change — confirm on Remedy Meds's site. Not medical advice; see our disclosure.

← Back to all rankings